Letters
Adverse effects of statins
Information about diabetogenic effect of statins is inadequate in France
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4385 (Published 15 July 2014) Cite this as: BMJ 2014;349:g4385
- Frédérick Stambach, general practitioner1,
- Philippe Nicot, general practitioner, expert for the Haute Autorité de Santé, and vice president of the FORMINDEP Association2,
- Jean Doubovetzky, general practitioner and senior writer for Prescrire journal3
- 1Lieudit La Mareille, 87400 Moissannes, France
- 275 Avenue Léon Blum, 87350 Panazol, France
- 330 Rue Jules Amilhau, Résidence Chantilly, bâtiment B, appartement 65, 31100 Toulouse, France
- stambach.fred{at}orange.fr
We analysed the official information available in France for healthcare professionals and patients about the diabetogenic effect of statins after reading the editorial by Godlee.1
In March 2012, the European Medicines Agency (EMA) acknowledged the diabetogenic effect of statins and demanded that summaries of product characteristics and package leaflets for all statins be modified.2
We …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.